Lynx1 Capital Management LP Diversified Active

CIK: 0001910456 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $151,186 (100.0% shares, 0.0% debt)

Holdings (18)

CABA CABALETTA BIO INC 21.2%

Value ($000) $32,053 Shares 2,106,000 Est. Cost $3.64 Unrealized +275.3%

— ALPINE IMMUNE SCIENCES INC 18.2%

Value ($000) $27,533 Shares 2,404,614 Est. Cost $10.20 Unrealized —

— MERUS N V 17.9%

Value ($000) $27,122 Shares 1,150,225 Est. Cost $24.66 Unrealized —

— CYMABAY THERAPEUTICS INC 9.8%

Value ($000) $14,823 Shares 994,161 Est. Cost $3.16 Unrealized —

TCRX TSCAN THERAPEUTICS INC 8.8%

Value ($000) $13,375 Shares 5,224,600 Est. Cost $2.68 Unrealized -12.9%

GHRS GH RESEARCH PLC 7.3%

Value ($000) $11,087 Shares 1,103,178 Est. Cost $10.41 Unrealized +11.0%

STOK STOKE THERAPEUTICS INC 4.5%

Value ($000) $6,738 Shares 1,710,154 Est. Cost $6.58 Unrealized 0.0%

AUTL AUTOLUS THERAPEUTICS PLC 2.1%

Value ($000) $3,176 Shares 1,363,025 Est. Cost $2.33 Unrealized —

— PIERIS PHARMACEUTICALS INC 1.9%

Value ($000) $2,913 Shares 9,775,849 Est. Cost $1.23 Unrealized —

— KINNATE BIOPHARMA INC 1.8%

Value ($000) $2,796 Shares 1,997,006 Est. Cost $10.62 Unrealized —

SLN SILENCE THERAPEUTICS PLC 1.5%

Value ($000) $2,315 Shares 235,787 Est. Cost $9.82 Unrealized —

— BIONOMICS LIMITED 1.5%

Value ($000) $2,202 Shares 815,512 Est. Cost $2.70 Unrealized —

CCCC C4 THERAPEUTICS INC 1.3%

Value ($000) $1,896 Shares 1,019,230 Est. Cost $3.05 Unrealized 0.0%

— THESEUS PHARMACEUTICALS INC 1.2%

Value ($000) $1,889 Shares 702,415 Est. Cost $8.59 Unrealized —

— NEKTAR THERAPEUTICS 0.7%

Value ($000) $1,052 Shares 1,766,815 Est. Cost $0.60 Unrealized —

— PASSAGE BIO INC 0.1%

Value ($000) $125 Shares 190,124 Est. Cost $1.43 Unrealized —

ZURA ZURA BIO LTD 0.0%

Value ($000) $65 Shares 9,917 Est. Cost $6.68 Unrealized 0.0%

— DBV TECHNOLOGIES S A 0.0%

Value ($000) $25 Shares 18,265 Est. Cost $1.90 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CABA	CABALETTA BIO INC	2,106,000	$32,053	21.2%	$3.64	+275.3%	COM	12674W109
—	ALPINE IMMUNE SCIENCES INC	2,404,614	$27,533	18.2%	$10.20	—	COM	02083G100
—	MERUS N V	1,150,225	$27,122	17.9%	$24.66	—	COM	N5749R100
—	CYMABAY THERAPEUTICS INC	994,161	$14,823	9.8%	$3.16	—	COM	23257D103
TCRX	TSCAN THERAPEUTICS INC	5,224,600	$13,375	8.8%	$2.68	-12.9%	COM	89854M101
GHRS	GH RESEARCH PLC	1,103,178	$11,087	7.3%	$10.41	+11.0%	ORDINARY SHARES	G3855L106
STOK	STOKE THERAPEUTICS INC	1,710,154	$6,738	4.5%	$6.58	0.0%	COM	86150R107
AUTL	AUTOLUS THERAPEUTICS PLC	1,363,025	$3,176	2.1%	$2.33	—	SPON ADS	05280R100
—	PIERIS PHARMACEUTICALS INC	9,775,849	$2,913	1.9%	$1.23	—	COM	720795103
—	KINNATE BIOPHARMA INC	1,997,006	$2,796	1.8%	$10.62	—	COM	49705R105
SLN	SILENCE THERAPEUTICS PLC	235,787	$2,315	1.5%	$9.82	—	ADS	82686Q101
—	BIONOMICS LIMITED	815,512	$2,202	1.5%	$2.70	—	ADS	09063M205
CCCC	C4 THERAPEUTICS INC	1,019,230	$1,896	1.3%	$3.05	0.0%	COM STK	12529R107
—	THESEUS PHARMACEUTICALS INC	702,415	$1,889	1.2%	$8.59	—	COM	88369M101
—	NEKTAR THERAPEUTICS	1,766,815	$1,052	0.7%	$0.60	—	COM	640268108
—	PASSAGE BIO INC	190,124	$125	0.1%	$1.43	—	COM	702712100
ZURA	ZURA BIO LTD	9,917	$65	0.0%	$6.68	0.0%	CLASS A ORD SHS	G9TY5A101
—	DBV TECHNOLOGIES S A	18,265	$25	0.0%	$1.90	—	SPONSORED ADR	23306J101